Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil cytosolic factor 1C (NCF1C) is a pseudogene highly similar in sequence to the functional neutrophil cytosolic factor 1 (NCF1) gene, which encodes the 47 kDa cytosolic subunit (p47phox) of the phagocyte NADPH oxidase complex. The NCF1C pseudogene, found near NCF1 on chromosome 7q11.23, carries a frameshift mutation (dinucleotide delta-GT deletion in exon 2) that results in a truncated, nonfunctional open reading frame, and it is not believed to produce a protein. NCF1C is not a protein-coding gene and plays no direct biological or therapeutic role; however, recombination events between NCF1 and its related pseudogenes (such as NCF1C) can lead to inactivation of NCF1, contributing to chronic granulomatous disease. NCF1C is not itself a therapeutic target, and there are no known drugs, disease roles, or direct biological functions associated with it[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil cytosolic factor 1C (NCF1C).